APTAMER GROUP PLC (APTA) — Interim Results

Investor webinar replay

Replay transcript excerpt

Good afternoon, and welcome to the APTAMER GROUP PLC investor presentation. Throughout this recorded presentation, investors will be in listen only mode. Questions are encouraged and could be submitted at any time via the q and a tab situated on the right hand corner of your screen. Simply type in your questions and press send. The company may not be in a position to answer every question it receives during the meeting itself. However, the company can review all questions submitted today and publish responses where it's appropriate to do so. Before we begin, I'd like to submit the following poll. I'd now like to hand you over to doctor Aaron Tolley, CEO. Good afternoon, sir. Good afternoon. Thank you. So thank you for taking the time to listen to our results, for the six months to the 12/31/2025. I'll just skip through the obligatory disclaimer slides before coming on to introduction. So I'll just introduce myself first. So I'm Aaron. I'm cofounder of APTAMER GROUP. Founded the company in 2008. I have a PhD in structural biology and biophysics. And for my sins, I've run the company for, the past fifteen or sixteen years. Good afternoon, everybody. I'm Andrew Rappson, CFO at APTAMER GROUP. I have over twenty years experience now as a chartered accountant. Joined APTAMER in August 22, and I've been CFO since August 23. And I've worked in the AIM environment now for, just over ten years. Okay. So I thought we'd start with a a quick brief overview for those people who are not familiar with the company. So we're a small biotech based in The UK. We have a global reputation for developing our version of APTAMER, which are optimist through our proprietary high throughput automated selection platform. The founders, David Bunker and myself, we've spent the last fifteen years b...